event
The Alumni Association of KAIST hosted the first KAIST Technology Exchange Meeting on September 12th at the KAIST Institute on campus.
About 14 alumni companies, MDS Technology, Biospace, and Satrec Initiative, two private equity funds including KAIST Entrepreneurship Foundation, and KAIST Technology Commercialization Center participated in this meeting.
This meeting was organized by the Alumni Association of KAIST in order to strengthen cooperation between alumni companies and KAIST members by increasing technology exchange and fostering cooperative culture.
The meeting comprised of two sessions: product exhibition and technology-exchange session.
During the exhibition, participating companies prepared the following: product showcase, intellectual property exchange, project consulting, and employment information.
Companies involved in technology-exchange session not only showcased their brand new technology but also shared their innovative ideas and entrepreneur vision, and discussed joint R&D.
The president of the Alumni Association of KAIST, Man Kee Baek who was in charge of this meeting said, “I hope this meeting stimulates more technology exchange between alumni companies and school members.”
He added that “our alumni association will continue to organize many projects for better KAIST.”
Detailed information about the event can be found on the official webpage of the Alumni Association of KAIST (http://www.ilovekaist.net), and this event was open to the public.
A company specializing in medical devices, Biospace, plans to donate a body composition analyzer and an automatic blood pressure meter worth 14,000,000 won to KAIST.
-
research KAIST Develops a Multifunctional Structural Battery Capable of Energy Storage and Load Support
Structural batteries are used in industries such as eco-friendly, energy-based automobiles, mobility, and aerospace, and they must simultaneously meet the requirements of high energy density for energy storage and high load-bearing capacity. Conventional structural battery technology has struggled to enhance both functions concurrently. However, KAIST researchers have succeeded in developing foundational technology to address this issue. < Photo 1. (From left) Professor Seong Su Kim, PhD
2024-11-27 -
event KAIST Office of Global Initiative Hosts 2024 Global Startup Internship Seminar
< Photo of ImpriMed CEO Sungwon Lim’s lecture > The Office of Global Initiative at KAIST successfully hosted the 2024 Global Startup Internship Seminar (GSIS) from Wednesday, November 20, to Friday, November 22. Now in its third year, following the 2022 Global Startup Internship Fair, the GSIS aims to introduce KAIST students to internship opportunities at U.S.-based startups and encourage participation in global internship programs, particularly for students with entrepreneu
2024-11-25 -
research KAIST Secures Core Technology for Ultra-High-Resolution Image Sensors
A joint research team from Korea and the United States has developed next-generation, high-resolution image sensor technology with higher power efficiency and a smaller size compared to existing sensors. Notably, they have secured foundational technology for ultra-high-resolution shortwave infrared (SWIR) image sensors, an area currently dominated by Sony, paving the way for future market entry. KAIST (represented by President Kwang Hyung Lee) announced on the 20th of November that a research t
2024-11-22 -
event KAIST’s RAIBO2 becomes the World’s First Robo-dog to Successfully Complete a Full-course Marathon
KAIST's quadrupedal walking robot "RAIBO", which can run seamlessly on sandy beaches, has now evolved into "RAIBO2"and achieved the groundbreaking milestone by becomeing the world's first quadrupedal robot to successfully complete a full-course marathon in an official event. < Photo 1. A group photo of RAIBO2 and the team after completing the full-course marathon > KAIST (President Kwang Hyung Lee) announced on the 17th of November that Professor Je Min Hwangbo's research team of t
2024-11-17 -
research KAIST Unveils New Possibilities for Treating Intractable Brain Tumors
< Photo 1. (From left) Professor Heung Kyu Lee, KAIST Department of Biological Sciences, and Dr. Keun Bon Ku > Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in cancer treatment. However, in the case of glioblastoma, an aggressive and treatment-resistant brain tumor, numerous clinical trials have failed to confirm their efficacy. Korean researchers have recently analyzed the mechanisms that cause T cell exhaus
2024-11-15